The pending deal poses risks to Allete’s financial health and ratepayers, and the proposed private equity model isn’t in the public interest, an administrative law judge said.

Much of Wall Street is expecting a possible market slowdown in the second half of the year, so it’s a good thing it hit some high notes beforehand. It’s earnings season, which is often a time to ...

BlackRock's assets under management hit a new high in the second quarter as global markets rallied, but its shares tumbled as ...

The non-binding opinion will inform the Minnesota Public Utilities Commission on whether it should approve the sale this fall ...

Private-credit firms tend to accept much higher loan-to-value ratios than banks, raising default risks, Moody's says. Bank of New York Mellon logged higher-than-expected earnings and revenue in the ...

The transit software company, is finally taking the step into public markets with an IPO after abandoning the idea in 2021.

Strategy's convertible debt, valued at $8.2 billion, now has a $5.2 billion market premium as its stock price approaches $450 ...

Trump traveled to Pennsylvania to tout new corporate investments in energy and technology, some of which predate his tenure.

Robotics is another big focus for the Trump administration in the AI race. Defense contractor Bechtel Plant Machinery ...

Corporate home buying continues to climb. Institutional investors bought 15 percent of U.S. homes for sale in the first quarter of 2021, which climbed to nearly 27 percent by early 2025. In some ...

The bank reported a second-quarter profit of $4.02 billion, or $1.96 a share, compared with $3.22 billion, or $1.52 a share, in the year-ago period. Analysts polled by FactSet expected $1.61 per share ...

The shares of Biocon rose over 1% during trade so far. The scrip had risen as much as 3.96% and is currently trading 1.31% higher at Rs 395. The scrip was trading higher and gains compare to a 0.21% ...